IRIS
MONTEMURRO, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.012
Totale 1.012
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.012
Totale 1.012
Salva come PNG Salva come JPEG
Città #
Genova 612
Genoa 157
Rapallo 148
Vado Ligure 95
Totale 1.012
Salva come PNG Salva come JPEG
Nome #
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies 133
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study 126
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey 125
Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence 120
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity 112
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 100
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer 97
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 68
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: Extending endocrine sensitivity 59
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 36
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 35
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer 22
Reply to A. S{\'a}nchez-Mu{\~n}oz et al 15
Totale 1.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.145
article - articoli 4.145
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 29 35 59 33 38 41 28 8
2020/2021124 8 12 11 8 5 16 4 20 4 19 9 8
2021/2022120 6 4 12 11 4 10 2 24 11 6 5 25
2022/2023176 14 20 2 18 25 22 0 13 29 1 31 1
2023/2024121 4 9 7 20 11 17 6 1 4 12 7 23
2024/2025106 19 22 12 20 33 0 0 0 0 0 0 0
Totale 1.048